GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nipro Corp (TSE:8086) » Definitions » Cyclically Adjusted PB Ratio

Nipro (TSE:8086) Cyclically Adjusted PB Ratio : 1.06 (As of May. 23, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Nipro Cyclically Adjusted PB Ratio?

As of today (2024-05-23), Nipro's current share price is 円1173.50. Nipro's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was 円1,110.64. Nipro's Cyclically Adjusted PB Ratio for today is 1.06.

The historical rank and industry rank for Nipro's Cyclically Adjusted PB Ratio or its related term are showing as below:

TSE:8086' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.95   Med: 1.32   Max: 1.95
Current: 1.07

During the past years, Nipro's highest Cyclically Adjusted PB Ratio was 1.95. The lowest was 0.95. And the median was 1.32.

TSE:8086's Cyclically Adjusted PB Ratio is ranked better than
71.7% of 470 companies
in the Medical Devices & Instruments industry
Industry Median: 2.13 vs TSE:8086: 1.07

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Nipro's adjusted book value per share data for the three months ended in Dec. 2023 was 円1,492.305. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円1,110.64 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Nipro Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Nipro's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nipro Cyclically Adjusted PB Ratio Chart

Nipro Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.40 1.48 1.08 0.98 -

Nipro Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.98 0.96 1.11 1.00 -

Competitive Comparison of Nipro's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Nipro's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nipro's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nipro's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Nipro's Cyclically Adjusted PB Ratio falls into.



Nipro Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Nipro's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1173.50/1110.64
=1.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nipro's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Nipro's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1492.305/106.8000*106.8000
=1,492.305

Current CPI (Dec. 2023) = 106.8000.

Nipro Quarterly Data

Book Value per Share CPI Adj_Book
201403 832.123 95.700 928.639
201406 825.807 98.000 899.961
201409 833.005 98.500 903.197
201412 941.372 97.900 1,026.951
201503 988.783 97.900 1,078.672
201506 986.341 98.400 1,070.541
201509 990.009 98.500 1,073.431
201512 988.163 98.100 1,075.798
201603 977.637 97.900 1,066.513
201606 878.022 98.100 955.889
201609 839.251 98.000 914.612
201612 907.269 98.400 984.719
201703 999.525 98.100 1,088.168
201706 1,040.064 98.500 1,127.704
201709 1,083.336 98.800 1,171.056
201712 1,108.697 99.400 1,191.236
201803 1,037.249 99.200 1,116.716
201806 1,011.092 99.200 1,088.555
201809 1,043.686 99.900 1,115.772
201812 984.427 99.700 1,054.532
201903 990.129 99.700 1,060.640
201906 984.506 99.800 1,053.560
201909 957.719 100.100 1,021.822
201912 979.638 100.500 1,041.048
202003 912.236 100.300 971.354
202006 888.159 99.900 949.503
202009 917.006 99.900 980.343
202012 937.933 99.300 1,008.774
202103 987.290 99.900 1,055.481
202106 1,059.339 99.500 1,137.059
202109 1,086.157 100.100 1,158.857
202112 1,101.939 100.100 1,175.695
202203 1,135.754 101.100 1,199.788
202206 1,237.227 101.800 1,297.995
202209 1,355.175 103.100 1,403.809
202212 1,367.272 104.100 1,402.734
202303 1,265.003 104.400 1,294.084
202306 1,306.225 105.200 1,326.092
202309 1,453.770 106.200 1,461.983
202312 1,492.305 106.800 1,492.305

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Nipro  (TSE:8086) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Nipro Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Nipro's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Nipro (TSE:8086) Business Description

Traded in Other Exchanges
Address
3-9-3 Honjo-Nishi Kita-ku, Osaka, JPN, 531-8510
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.

Nipro (TSE:8086) Headlines

No Headlines